Entera Bio Ltd - ESG Rating & Company Profile powered by AI
If you are employed by Entera Bio Ltd and you would like to licence your ESG rating, please contact us. The webpage contains a zero-cost Sustainability analysis for Entera Bio Ltd. The webpage includes a questions and answers section on Entera Bio Ltd.
Entera Bio Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 4.0 and governance score of 3.4.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1659 | Vivo Cannabis Inc | 3.4 | Medium |
| 1659 | Verve Therapeutics Inc | 3.4 | Medium |
| 1705 | Entera Bio Ltd | 3.3 | Medium |
| 1705 | Benitec Biopharma Ltd | 3.3 | Medium |
| 1705 | Flexion Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Entera Bio Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Entera Bio Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Entera Bio Ltd report the average age of the workforce?
Sign up for free to unlockDoes Entera Bio Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Entera Bio Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Entera Bio Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Entera Bio Ltd offer flexible work?
Sign up for free to unlockDoes Entera Bio Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Entera Bio Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Entera Bio Ltd conduct supply chain audits?
Sign up for free to unlockDoes Entera Bio Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Entera Bio Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Entera Bio Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Entera Bio Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Entera Bio Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Entera Bio Ltd disclose water use targets?
Sign up for free to unlockDoes Entera Bio Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Entera Bio Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Entera Bio Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Entera Bio Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Entera Bio Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Entera Bio Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Entera Bio Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Entera Bio Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Entera Bio Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Entera Bio Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Entera Bio Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Entera Bio Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Entera Bio Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Entera Bio Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Entera Bio Ltd disclose its waste policy?
Sign up for free to unlockDoes Entera Bio Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Entera Bio Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Entera Bio Ltd disclose energy use targets?
Sign up for free to unlockDoes Entera Bio Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Entera Bio Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Entera Bio Ltd
These potential risks are based on the size, segment and geographies of the company.
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.